The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male

被引:22
作者
Mansyur, Makbul Aman [1 ]
Bakri, Syakib [2 ]
Patellongi, Ilham Jaya [3 ]
Rahman, Ilham Akbar [4 ]
机构
[1] Hasanuddin Univ, Dept Internal Med, Div Endocrinol Diabet & Metab, Fac Med, Makassar, Indonesia
[2] Hasanuddin Univ, Dept Internal Med, Div Nephrol & Hypertens, Fac Med, Makassar, Indonesia
[3] Hasanuddin Univ, Dept Physiol, Fac Med, Makassar, Indonesia
[4] Hasanuddin Univ, Fac Med, Makassar, Indonesia
关键词
Risk factors; Insulin resistance; Obesity; Adolescence; Childhood; C-reactive protein; Triacylglycerol; Indonesia; Type 2 diabetes mellitus; HIGH-DENSITY-LIPOPROTEINS; TYPE-2; DIABETES-MELLITUS; CARDIOVASCULAR RISK; OBESITY; CHILDREN; PANEL; CHOLESTEROL; MECHANISMS; CRITERIA; DISEASE;
D O I
10.1016/j.clnesp.2019.12.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and aims: Millions of people in Indonesia have diabetes. The cluster of metabolic abnormalities has long been identified as the risk factors for type 2 diabetes and is now commonly described as metabolic syndrome/MetS. Insulin resistance takes a key role in the process of the MetS and has even been hypothesized as its underlying cause. Clinical and epidemiologic studies also indicate that inflammatory factors might be correlated with IR. Prospective studies have proved that metabolic syndrome grows during childhood/adolescence and progresses to adulthood T2DM. The purpose of this study was to investigate relationships between metabolic syndrome components and low-grade systemic inflammation with insulin resistance in non-diabetic Indonesian adolescent male. Methods: This was a cross-sectional analysis of non-diabetic adolescent male in Indonesian population (n = 128) aged between 18 and 22 years old. MetS components are based on NCEP ATP III (2004) modification for Asia Pacific population. Marker for low-grade systemic inflammation is hsCRP and insulin resistance was determined by HOMA-IR formula. Relevant measures were anthropometry, blood pressure, fasting insulin, serum glucose, lipid profiles and hsCRP. Results: Of the 128 adolescent male, we found that 16 subjects (12.5%) have central obesity; 3 subjects (2.3%) have hyperglycemia; 26 subjects (20.3%) have low HDL-c; 19 subjects (14.8%) have high triacylglycerol; 45 subjects (35.2%) have hsCRP >= 1.0 mg/dL; 4 subjects (3.1%) have high blood pressure and 39 subjects (30.5%) have insulin resistance. The association of MetS components with the risk of insulin resistance is central obesity and high triacylglycerol with OR of 24.4 (95%CI: 5.19-114.42) and 9.4 (95%CI: 3.09-28.68) consecutively. We also found that low-grade systemic inflammation (hsCRP >1.0 mg/dL) was strongly associated with incident of insulin resistance with OR 5.2 (95%CI: 2.31-11.64). Meanwhile, we found that high triacylglycerol level is the solely one of five MetS components which has contribution to the incident of systemic low-grade inflammation with OR 3.9 (95%CI: 1.43-10.92). Conclusion: Central obesity and high triacylglycerol level are the important MetS components associated with IR. Systemic low-grade inflammation has been associated with insulin resistance. Identification of obesity, high triacylglycerol and high hsCRP should be focused for prevention of type 2 diabetes in nondiabetic Indonesian adolescent male. (c) 2019 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 45 条
[1]  
[Anonymous], 2013, IDF DIABETES ATLAS
[2]  
[Anonymous], 2007, IDF CONS DEF MET SYN
[3]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[4]  
Caprio S, 2002, J PEDIATR ENDOCR MET, V15, P487
[5]   Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children [J].
Caprio, S ;
Bronson, M ;
Sherwin, RS ;
Rife, F ;
Tamborlane, WV .
DIABETOLOGIA, 1996, 39 (12) :1489-1497
[6]   Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome [J].
Carr, DB ;
Utzschneider, KM ;
Hull, RL ;
Kodama, K ;
Retzlaff, BM ;
Brunzell, JD ;
Shofer, JB ;
Fish, BE ;
Knopp, RH ;
Kahn, SE .
DIABETES, 2004, 53 (08) :2087-2094
[7]   Obesity, insulin resistance and comorbidities - Mechanisms of association [J].
Castro, Ana Valeria B. ;
Kolka, Cathryn M. ;
Kim, Stella P. ;
Bergman, Richard N. .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (06) :600-609
[8]   Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome [J].
Cheal, KL ;
Abbasi, F ;
Lamendola, C ;
McLaughlin, T ;
Reaven, GM ;
Ford, ES .
DIABETES, 2004, 53 (05) :1195-1200
[9]   Insulin resistance and obesity in childhood [J].
Chiarelli, Francesco ;
Marcovecchio, Maria Loredana .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 :S67-S74
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497